| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Laura Whiteley, Elizabeth M Olsen, Kayla K Haubrick, Chaerim Kang, Ian Vaughan, Larry K Brow. A Review of Digital Interventions to Decrease Cannabis Use Among Patients With Comorbid Psychiatric Disorders. Journal of dual diagnosis. 2022-09-30. PMID:36178356. |
cannabis use disorder (cud) is associated with an elevated risk for psychiatric disorders and symptoms, contributing to poor health outcomes and increased medical costs. |
2022-09-30 |
2023-08-14 |
Not clear |
| Elias Ghossoub, Samer El Hayek, Khalid Trad, Fadi T Maalouf, Hani Tami. Association between Cannabis Use Disorder and Self- and Other-Directed Aggression. The journal of the American Academy of Psychiatry and the Law. 2022-09-30. PMID:36180127. |
the objective of the current study was to assess the nature of the association between cannabis use disorder (cud) and self-directed, other-directed, and combined aggression. |
2022-09-30 |
2023-08-14 |
Not clear |
| Catherine A Dennen, Kenneth Blum, Abdalla Bowirrat, Jag Khalsa, Panayotis K Thanos, David Baron, Rajendra D Badgaiyan, Ashim Gupta, Eric R Braverman, Mark S Gol. Neurogenetic and Epigenetic Aspects of Cannabinoids. Epigenomes. vol 6. issue 3. 2022-09-22. PMID:36135314. |
with increasing cannabis use comes the potential for an increase in abuse, and according to the substance abuse and mental health services administration (samhsa), approximately 5.1% of americans had cannabis use disorder (cud) in 2020. |
2022-09-22 |
2023-08-14 |
Not clear |
| Catherine A Dennen, Kenneth Blum, Abdalla Bowirrat, Jag Khalsa, Panayotis K Thanos, David Baron, Rajendra D Badgaiyan, Ashim Gupta, Eric R Braverman, Mark S Gol. Neurogenetic and Epigenetic Aspects of Cannabinoids. Epigenomes. vol 6. issue 3. 2022-09-22. PMID:36135314. |
research has shown that genetics and epigenetics play a significant role in cannabis use and cud. |
2022-09-22 |
2023-08-14 |
Not clear |
| Catherine A Dennen, Kenneth Blum, Abdalla Bowirrat, Jag Khalsa, Panayotis K Thanos, David Baron, Rajendra D Badgaiyan, Ashim Gupta, Eric R Braverman, Mark S Gol. Neurogenetic and Epigenetic Aspects of Cannabinoids. Epigenomes. vol 6. issue 3. 2022-09-22. PMID:36135314. |
in fact, approximately 50-70% of liability to cud and 40-48% of cannabis use initiation have been found to be the result of genetic factors. |
2022-09-22 |
2023-08-14 |
Not clear |
| Catherine A Dennen, Kenneth Blum, Abdalla Bowirrat, Jag Khalsa, Panayotis K Thanos, David Baron, Rajendra D Badgaiyan, Ashim Gupta, Eric R Braverman, Mark S Gol. Neurogenetic and Epigenetic Aspects of Cannabinoids. Epigenomes. vol 6. issue 3. 2022-09-22. PMID:36135314. |
cannabis usage and cud have also been linked to an increased risk of psychiatric disorders and reward deficiency syndrome (rds) subsets like schizophrenia, depression, anxiety, and substance use disorder. |
2022-09-22 |
2023-08-14 |
Not clear |
| Catherine A Dennen, Kenneth Blum, Abdalla Bowirrat, Jag Khalsa, Panayotis K Thanos, David Baron, Rajendra D Badgaiyan, Ashim Gupta, Eric R Braverman, Mark S Gol. Neurogenetic and Epigenetic Aspects of Cannabinoids. Epigenomes. vol 6. issue 3. 2022-09-22. PMID:36135314. |
in conclusion, having a better understanding of the epigenetic and genetic underpinnings of cannabis use, cud, and the endocannabinoid system as a whole will aid in the development of effective fda-approved treatment therapies and the advancement of personalized medicine. |
2022-09-22 |
2023-08-14 |
Not clear |
| Rynaz Rabiee, Andreas Lundin, Emilie Agardh, Peter Allebeck, Anna-Karin Danielsso. Cannabis use disorder in relation to socioeconomic factors and psychiatric comorbidity: A cluster analysis of three million individuals born in 1970-2000. Scandinavian journal of public health. 2022-09-19. PMID:36120841. |
cannabis use disorder (cud) is one of the main reasons for seeking substance use treatment. |
2022-09-19 |
2023-08-14 |
Not clear |
| Gregory R Niklason, Eric Rawls, Sisi Ma, Erich Kummerfeld, Andrea M Maxwell, Leyla R Brucar, Gunner Drossel, Anna Zilverstan. Explainable machine learning analysis reveals sex and gender differences in the phenotypic and neurobiological markers of Cannabis Use Disorder. Scientific reports. vol 12. issue 1. 2022-09-17. PMID:36115920. |
cannabis use disorder (cud) has been linked to a complex set of neuro-behavioral risk factors. |
2022-09-17 |
2023-08-14 |
Not clear |
| Larry Keen, Arlener D Turner, Toni Harris, Lauren George, Jonae Crum. Differences in internalizing symptoms between those with and without Cannabis Use Disorder among HBCU undergraduate students. Journal of American college health : J of ACH. 2022-09-15. PMID:36108170. |
to determine the differences in internalizing symptoms between those who met criteria for cannabis use disorder (cud) and those who did not in young adults attending a historically black college or university (hbcu). |
2022-09-15 |
2023-08-14 |
Not clear |
| Elizabeth R Aston, Benjamin L Bere. Cannabis Use Disorder: A Behavioral Economic Perspective. Current addiction reports. vol 9. issue 1. 2022-09-12. PMID:36091647. |
to explore relations between behavioral economic demand for cannabis and cannabis use disorder (cud). |
2022-09-12 |
2023-08-14 |
human |
| Elizabeth R Aston, Benjamin L Bere. Cannabis Use Disorder: A Behavioral Economic Perspective. Current addiction reports. vol 9. issue 1. 2022-09-12. PMID:36091647. |
complementing and enhancing prior work synthesizing research on cannabis demand, the present review endeavors to determine whether specific demand indices derived from the marijuana purchase task are most reliably related to cud. |
2022-09-12 |
2023-08-14 |
human |
| Christina C Tam, David A Gilder, Libo Li, Katherine J Karriker-Jaffe, Sarah E Duhart Clarke, Cindy L Ehler. Age of onset and alcohol and cannabis use disorders among Mexican American young adults: Robust substance-specific effects of early use as a risk factor. Journal of ethnicity in substance abuse. 2022-09-12. PMID:36093789. |
we investigated the substance-specific and cross-substance risk associated with early onset (before age 15) of drunkenness and cannabis use in the subsequent development of alcohol (aud) and cannabis use disorder (cud) in mexican american young adults. |
2022-09-12 |
2023-08-14 |
human |
| Ralph E Tarter, Maureen Reynolds, Michael Vanyukov, Levent Kirisc. Physical inactivity during adolescence heightens risk for cannabis use disorder in adulthood. Experimental and clinical psychopharmacology. 2022-09-01. PMID:36048110. |
the association between physical inactivity and substance use throughout adolescence was prospectively investigated in relation to developing cannabis use disorder (cud). |
2022-09-01 |
2023-08-14 |
Not clear |
| Guillaume Barbalat, Sze Li. Long-Term Impact of Medical Marijuana Laws on the Burden of Cannabis Use Disorders in US Male and Female Adolescents and Young Adults. Community mental health journal. 2022-08-29. PMID:36036345. |
here, we extracted data from the global burden of disease database to estimate the long-term effect (> 5 years) of medical marijuana laws (mml) on 2019 cannabis use disorders disability adjusted life years (2019 cud dalys) in us male and female adolescents (15-19 years old) and young adults (20-24 years old). |
2022-08-29 |
2023-08-14 |
Not clear |
| Yanning Zuo, Attilio Iemolo, Patricia Montilla-Perez, Hai-Ri Li, Xia Yang, Francesca Teles. Chronic adolescent exposure to cannabis in mice leads to sex-biased changes in gene expression networks across brain regions. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2022-08-22. PMID:35995972. |
during adolescence, frequent and heavy cannabis use can lead to serious adverse health effects and cannabis use disorder (cud). |
2022-08-22 |
2023-08-14 |
mouse |
| Sylvanus Toikumo, Heng Xu, Joel Gelernter, Rachel L Kember, Henry R Kranzle. Integrating human brain proteomic data with genome-wide association study findings identifies novel brain proteins in substance use traits. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2022-08-08. PMID:35941285. |
the 4 samples comprised gwas of european-ancestry individuals for smoking initiation [smk] (n = 1,232,091), alcohol use disorder [aud] (n = 313,959), cannabis use disorder [cud] (n = 384,032), and opioid use disorder [oud] (n = 302,585). |
2022-08-08 |
2023-08-14 |
human |
| Yanjia Cao, Marta M Jankowska, Jiue-An Yang, Yuyan Sh. Spatial and temporal pattern of cannabis use disorder in California 2010-2019. Spatial and spatio-temporal epidemiology. vol 42. 2022-08-07. PMID:35934327. |
as cannabis use is being legalized in an increasing number of states, it is important to understand the changing dynamic of the risk in cannabis use disorder (cud). |
2022-08-07 |
2023-08-14 |
Not clear |
| Tessa Robinson, Muhammad Usman Ali, Bethany Easterbrook, Stephanie Coronado-Montoya, Dimitri Daldegan-Bueno, Wayne Hall, Didier Jutras-Aswad, Benedikt Fische. Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis. Drug and alcohol dependence. vol 238. 2022-08-06. PMID:35932748. |
cannabis use disorder (cud) affects one-in-five cannabis users, presenting a major contributor to cannabis-associated disease burden. |
2022-08-06 |
2023-08-14 |
Not clear |
| Tessa Robinson, Muhammad Usman Ali, Bethany Easterbrook, Stephanie Coronado-Montoya, Dimitri Daldegan-Bueno, Wayne Hall, Didier Jutras-Aswad, Benedikt Fische. Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis. Drug and alcohol dependence. vol 238. 2022-08-06. PMID:35932748. |
epidemiological data identify the frequency of cannabis use as a risk factor for cud. |
2022-08-06 |
2023-08-14 |
Not clear |